Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.

@article{Arrain2008RecentRO,
  title={Recent recommendations on bisphosphonate-associated osteonecrosis of the jaw.},
  author={Yazdana Arrain and Tahir Masud},
  journal={Dental update},
  year={2008},
  volume={35 4},
  pages={
          238-40, 242
        }
}
UNLABELLED There is increasing awareness of the importance of osteonecrosis of the jaw developing in patients taking bisphosphonates. A recent working party of the American Society for Bone and Mineral Research has developed recommendations on the prevention and treatment of this condition which dentists will find useful. CLINICAL RELEVANCE As bisphosphonates are now being used widely in the treatment of several conditions including osteoporosis, Paget's disease and metastatic malignancy… 
View on PubMed
doi.org
21 Citations
Background Citations
3

21 Citations

Citation Type

Citation Type

A current update on osteonecrosis of the jaw and bisphosphonates.
TLDR
Bisphosphonate-associated osteonecrosis of the jaw (BONJ) is a rare but painful condition that can affect quality of life and healthcare professionals need to be aware of this potential side-effect.
Bisphosphonate osteonecrosis of the jaw--a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention.
[The risk of bisphosphonate-related osteonecrosis of the jaw].
TLDR
Dealing with this rare condition requires identification of at risk patients so as to apply preventative measures and a conservative treatment is usually preferred.
Bisphosphonate-induced osteonecrosis of the jaw: medical implications and dental complications
TLDR
Use of bisphosphonates for some years can lead to accumulation of old fragile bone, occlusion of haversian sinuses, and ultimately osteonecrosis and sequestrum formation.
The characteristics of bisphosphonate patients developing bisphosphonate-related osteonecrosis of the jaw attending an OMFS department.
TLDR
Patients taking bisphosphonate medication that suffer with bisph phosphonate-related osteonecrosis of the jaw (BRONJ) following an exodontia procedure were examined.
isphosphonate osteonecrosis of the jaw — a literature review f UK policies versus international policies on isphosphonates , risk factors and prevention
TLDR
The guidelines produced by national specialist medical associations and expert panels on the prevention of bisphosphonate osteonecrosis of the jaws are compared and the evidence behind these guidelines are reviewed.
The risk of bisphosphonate-related osteonecrosis of the jaw in children. A case report and literature review.
TLDR
Dental clinicians need to be aware of the potential risk of BRONJ in paediatric patients who have had intravenous bisphosphonate therapy and it is important that these patients are identified and managed appropriately.
BISPHOSPHONATES IN DENTISTRY AN ASIAN PERSPECTIVE – EVIDENCE BASED REVIEW -
TLDR
The objective of this review is to provide a comprehensive report on the drug bisphosphonate, clinical applications and its potential adverse effects, with special focus on Asian literature.
Guidelines for bisphosphonate-associated osteonecrosis of the jaw
TLDR
A consensus-based guideline was developed by a multidisciplinary task force including representatives from national and international societies representing the disciplines of oral surgery, dentistry, oral pathology, oral medicine, endocrinology, rheumatology and oncology for the diagnosis of bisphosphonate-associated osteonecrosis of the jaw.
Do specialists give consistent advice to primary care colleagues on antibiotic use in patients receiving bisphosphonates
TLDR
The results of a survey of the advice oral surgeons would give to PDCPs treating patients receiving bisphosphonates are presented, and the implications for patient care are discussed.
...
1
2
3
...

References

SHOWING 1-5 OF 5 REFERENCES
Bisphosphonate-associated Osteonecrosis of the jaws: a guide for the general dental practitioner.
TLDR
The aim of this article is to outline the proposed pathogenesis, incidence, presenting signs and symptoms, and risk factors of bisphosphonate-associated jaw osteonecrosis.
Bisphosphonate‐Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research
  • S. Khosla, D. Burr, +21 authors E. Shane
  • Medicine
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
  • 2007
TLDR
This report summarizes the findings and recommendations of the task force to address key questions related to case definition, epidemiology, risk factors, diagnostic imaging, clinical management, and future areas for research related to the disorder.
Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws: History, Etiology, Prevention, and Treatment
TLDR
The first cases of bisphosphonate-induced osteonecrosis of the maxilla and mandible were documented by Marx and Stern in 2002 in a textbook entitled Oral and Speech Pathology.
Oral & Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws: History, Etiology, Prevention, and Treatment
"Oral and Intravenous Bisphosphonate-Induced Osteonecrosis of the Jaws" deals with dentistry.
The cost of osteoporotic fractures in the UK: projections for 2000–2020
TLDR
A Markov model of the natural history of osteoporosis was used to predict fracture numbers and corresponding costs for the UK population aged 50-99 from 2000 to 2020 and the model predicts annual fractures will increase by 21% to 230,000 per year, with costs growing by 20% to over £2.1 billion per year.